Skip to content
TRACON Pharmaceuticals |Targeted Therapeutics for Cancer and Ophthalmology Logo TRACON Pharmaceuticals |Targeted Therapeutics for Cancer and Ophthalmology Logo TRACON Pharmaceuticals |Targeted Therapeutics for Cancer and Ophthalmology Logo
  • ABOUT
    • MANAGEMENT
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORY BOARD
  • PIPELINE
    • ENVAFOLIMAB (KN035)
    • TRC102
    • TJ004309
    • YH001
  • CLINICAL TRIALS
    • EXPANDED ACCESS POLICY
  • PARTNERS
  • NEWS
    • PRESS RELEASES
    • VIDEO PRESENTATIONS
  • INVESTORS
    • PRESS RELEASES
    • EVENTS & PRESENTATIONS
    • CORPORATE GOVERNANCE
    • FINANCIALS & FILINGS
      • SEC FILINGS
      • ANNUAL REPORTS & PROXIES
      • QUARTERLY REPORTS
    • STOCK INFORMATION
      • HISTORICAL PRICE LOOKUP
      • INVESTMENT CALCULATOR
    • INVESTOR FAQ
    • CONTACT
  • CONTACT
    • CAREERS
  • COMMUNITY
  • UNNECESSARY EXPENSE
Publicationsadmin2020-03-10T17:29:03+00:00

PUBLICATIONS

TRC253 Scientific Presentations

2019 ASCO, Abstract
2019 AACR, Preclinical Poster
2018 GU ASCO, TRC253 Phase 1/2 Trials in Progress Poster
2016 PCF Scientific Retreat, Preclinical Poster

TRC102 Scientific Presentations

2019 AACR TRC102 + Temodar Phase 2 Poster
2017 ASCO TRC102 + Temodar Phase 1 Poster
2016 ASCO TRC102 + Temodar Phase 1 Poster
2015 ASCO TRC102 + Temozolomide Phase 1 Poster
2015 AACR TRC102 + Temozolomide Phase 1 Poster
2014 ASH TRC102 + Fludarabine Phase 1 Poster
2012 AACR TRC102 + Temodar Phase 1b poster
2012 AACR TRC102 + Temodar Phase 1b PK data poster
2010 ASCO – Phase 1 slideshow
2010 ASCO – Phase 1 poster
2010 AACR– preclinical poster
2009 AACR– 3 preclinical posters
2007 EORTC-NCI-AACR

TRC102 Journal Publications

Caimi PF, et al. TRC102 + Fludara Phase 1 Trial
Gordon MS et al Investigational New Drugs 2012 (TRC102 Phase 1b)

TRC694 Scientific Presentations

TRC694, 2017 AACR Poster



4350 La Jolla Village Drive
Suite 800
San Diego, CA 92122
Phone: (858) 550-0780
Fax: (858) 550-0786
Email: info@traconpharma.com

ABOUT

  • Management
  • Board of Directors
  • Scientific Advisory Board

NEWS

  • Press Releases
  • Publications

PIPELINE

  • Envafolimab (KN035)
  • TRC102
  • TJ004309

PARTNERS

CONTACT

CLINICAL TRIALS

INVESTORS

  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Investor FAQ
  • Contact
Copyright © TRACON Pharmaceuticals, Inc | Digital Endeavor Websites
Page load link
Go to Top